Since the beginning of the year, shares of consumer cannabis company HEXO (NYSE: HEXO) have declined by more than 50%. Compared to the S&P 500's decline of just 3% year to date, HEXO's share performance is abysmal.
Indeed, although the company's core business is growing, HEXO's total number of shares outstanding has been diluted by 75% since January , and the company continues to raise cash with no end in sight.
While investors are concerned about HEXO's capital woes, the company has been making significant progress with its expansion. More and more investors are beginning to show interest in the stock now that its annual production capacity may expand significantly. Let's look at why everyone is talking about HEXO's stock and why it is a solid buy.